What is Iradimed Corp worth?
With the base-case assumptions below, a discounted cash flow model on Iradimed Corp's reported free cash flow gives $48.76 per share. The share price was $85.76 on September 25, 2026, 76% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $31.43 | -63% |
| Base | 15.0% | 9.0% | $48.76 | -43% |
| Bull | 20.0% | 8.0% | $81.03 | -6% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $61.88 | $65.97 | $70.97 | $77.22 | $85.26 |
| 8.0% | $52.02 | $54.68 | $57.81 | $61.58 | $66.17 |
| 9.0% | $44.85 | $46.67 | $48.76 | $51.20 | $54.09 |
| 10.0% | $39.42 | $40.71 | $42.17 | $43.84 | $45.77 |
| 11.0% | $35.16 | $36.11 | $37.16 | $38.35 | $39.70 |
Where the presets come from
Base: years 1 to 5 grow at Iradimed Corp's revenue growth rate over the last 5 fiscal years (21.5% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions